Global Veterinary Regenerative Medicine Supply, Demand and Key Producers, 2023-2029
The global Veterinary Regenerative Medicine market size is expected to reach $ 607.7 million by 2029, rising at a market growth of 12.1% CAGR during the forecast period (2023-2029).
Regenerative medicine therapy has grown in popularity in both human and veterinary medicine for the treatment of a variety of disease conditions. In the rapidly developing field of veterinary regenerative medicine, cells, and tissues-such as live cells, serum, or bone-are utilized in animals with the hopes of restoring diseased or damaged tissues or organs. Recent studies have shown that it is effective in controlling a variety of orthopedic disorders in companion animals, including osteoarthritis and soft tissue injuries. Regenerative medicine is increasingly used as an alternative to surgical, medicinal, and rehabilitation therapy or as a multimodal approach to treating a condition or injury.
Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types.
This report studies the global Veterinary Regenerative Medicine demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Veterinary Regenerative Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Veterinary Regenerative Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Veterinary Regenerative Medicine total market, 2018-2029, (USD Million)
Global Veterinary Regenerative Medicine total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Veterinary Regenerative Medicine total market, key domestic companies and share, (USD Million)
Global Veterinary Regenerative Medicine revenue by player and market share 2018-2023, (USD Million)
Global Veterinary Regenerative Medicine total market by Type, CAGR, 2018-2029, (USD Million)
Global Veterinary Regenerative Medicine total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Veterinary Regenerative Medicine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ACell Inc. (Integra LifeSciences), Animal Cell Therapies, Inc., Ardent, Boehringer Ingelheim International GmbH, Cell Therapy Sciences, Dechra, Enso Discoveries, South Paws Veterinary Surgical Specialists and Veterinary Specialty Center, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Veterinary Regenerative Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Veterinary Regenerative Medicine Market, By Region:
1. How big is the global Veterinary Regenerative Medicine market?
2. What is the demand of the global Veterinary Regenerative Medicine market?
3. What is the year over year growth of the global Veterinary Regenerative Medicine market?
4. What is the total value of the global Veterinary Regenerative Medicine market?
5. Who are the major players in the global Veterinary Regenerative Medicine market?
6. What are the growth factors driving the market demand?
Regenerative medicine therapy has grown in popularity in both human and veterinary medicine for the treatment of a variety of disease conditions. In the rapidly developing field of veterinary regenerative medicine, cells, and tissues-such as live cells, serum, or bone-are utilized in animals with the hopes of restoring diseased or damaged tissues or organs. Recent studies have shown that it is effective in controlling a variety of orthopedic disorders in companion animals, including osteoarthritis and soft tissue injuries. Regenerative medicine is increasingly used as an alternative to surgical, medicinal, and rehabilitation therapy or as a multimodal approach to treating a condition or injury.
Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types.
This report studies the global Veterinary Regenerative Medicine demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Veterinary Regenerative Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Veterinary Regenerative Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Veterinary Regenerative Medicine total market, 2018-2029, (USD Million)
Global Veterinary Regenerative Medicine total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Veterinary Regenerative Medicine total market, key domestic companies and share, (USD Million)
Global Veterinary Regenerative Medicine revenue by player and market share 2018-2023, (USD Million)
Global Veterinary Regenerative Medicine total market by Type, CAGR, 2018-2029, (USD Million)
Global Veterinary Regenerative Medicine total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Veterinary Regenerative Medicine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ACell Inc. (Integra LifeSciences), Animal Cell Therapies, Inc., Ardent, Boehringer Ingelheim International GmbH, Cell Therapy Sciences, Dechra, Enso Discoveries, South Paws Veterinary Surgical Specialists and Veterinary Specialty Center, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Veterinary Regenerative Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Veterinary Regenerative Medicine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Platelet-Rich Plasma (PRP)
- Stem Cell Therapy
- Others
- Veterinary Hospitals/Clinics
- Veterinary Research Institutes
- ACell Inc. (Integra LifeSciences)
- Animal Cell Therapies, Inc.
- Ardent
- Boehringer Ingelheim International GmbH
- Cell Therapy Sciences
- Dechra
- Enso Discoveries
- South Paws Veterinary Surgical Specialists
- Veterinary Specialty Center
- Vetbiologics
- Vetherapy
- VetStem, Inc.
- Zoetis
1. How big is the global Veterinary Regenerative Medicine market?
2. What is the demand of the global Veterinary Regenerative Medicine market?
3. What is the year over year growth of the global Veterinary Regenerative Medicine market?
4. What is the total value of the global Veterinary Regenerative Medicine market?
5. Who are the major players in the global Veterinary Regenerative Medicine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Veterinary Regenerative Medicine Introduction
1.2 World Veterinary Regenerative Medicine Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Veterinary Regenerative Medicine Total Market by Region (by Headquarter Location)
1.3.1 World Veterinary Regenerative Medicine Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.3 China Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.4 Europe Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.5 Japan Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.6 South Korea Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.7 ASEAN Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.8 India Veterinary Regenerative Medicine Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Veterinary Regenerative Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Veterinary Regenerative Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.2 World Veterinary Regenerative Medicine Consumption Value by Region
2.2.1 World Veterinary Regenerative Medicine Consumption Value by Region (2018-2023)
2.2.2 World Veterinary Regenerative Medicine Consumption Value Forecast by Region (2024-2029)
2.3 United States Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.4 China Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.5 Europe Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.6 Japan Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.7 South Korea Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.8 ASEAN Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.9 India Veterinary Regenerative Medicine Consumption Value (2018-2029)
3 WORLD VETERINARY REGENERATIVE MEDICINE COMPANIES COMPETITIVE ANALYSIS
3.1 World Veterinary Regenerative Medicine Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Veterinary Regenerative Medicine Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Veterinary Regenerative Medicine in 2022
3.2.3 Global Concentration Ratios (CR8) for Veterinary Regenerative Medicine in 2022
3.3 Veterinary Regenerative Medicine Company Evaluation Quadrant
3.4 Veterinary Regenerative Medicine Market: Overall Company Footprint Analysis
3.4.1 Veterinary Regenerative Medicine Market: Region Footprint
3.4.2 Veterinary Regenerative Medicine Market: Company Product Type Footprint
3.4.3 Veterinary Regenerative Medicine Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Veterinary Regenerative Medicine Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Veterinary Regenerative Medicine Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Veterinary Regenerative Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Veterinary Regenerative Medicine Consumption Value Comparison
4.2.1 United States VS China: Veterinary Regenerative Medicine Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Veterinary Regenerative Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Veterinary Regenerative Medicine Companies and Market Share, 2018-2023
4.3.1 United States Based Veterinary Regenerative Medicine Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023)
4.4 China Based Companies Veterinary Regenerative Medicine Revenue and Market Share, 2018-2023
4.4.1 China Based Veterinary Regenerative Medicine Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023)
4.5 Rest of World Based Veterinary Regenerative Medicine Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Veterinary Regenerative Medicine Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Veterinary Regenerative Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Platelet-Rich Plasma (PRP)
5.2.2 Stem Cell Therapy
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Veterinary Regenerative Medicine Market Size by Type (2018-2023)
5.3.2 World Veterinary Regenerative Medicine Market Size by Type (2024-2029)
5.3.3 World Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Veterinary Regenerative Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Veterinary Hospitals/Clinics
6.2.2 Veterinary Research Institutes
6.3 Market Segment by Application
6.3.1 World Veterinary Regenerative Medicine Market Size by Application (2018-2023)
6.3.2 World Veterinary Regenerative Medicine Market Size by Application (2024-2029)
6.3.3 World Veterinary Regenerative Medicine Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 ACell Inc. (Integra LifeSciences)
7.1.1 ACell Inc. (Integra LifeSciences) Details
7.1.2 ACell Inc. (Integra LifeSciences) Major Business
7.1.3 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product and Services
7.1.4 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 ACell Inc. (Integra LifeSciences) Recent Developments/Updates
7.1.6 ACell Inc. (Integra LifeSciences) Competitive Strengths & Weaknesses
7.2 Animal Cell Therapies, Inc.
7.2.1 Animal Cell Therapies, Inc. Details
7.2.2 Animal Cell Therapies, Inc. Major Business
7.2.3 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product and Services
7.2.4 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Animal Cell Therapies, Inc. Recent Developments/Updates
7.2.6 Animal Cell Therapies, Inc. Competitive Strengths & Weaknesses
7.3 Ardent
7.3.1 Ardent Details
7.3.2 Ardent Major Business
7.3.3 Ardent Veterinary Regenerative Medicine Product and Services
7.3.4 Ardent Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Ardent Recent Developments/Updates
7.3.6 Ardent Competitive Strengths & Weaknesses
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Details
7.4.2 Boehringer Ingelheim International GmbH Major Business
7.4.3 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product and Services
7.4.4 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
7.4.6 Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
7.5 Cell Therapy Sciences
7.5.1 Cell Therapy Sciences Details
7.5.2 Cell Therapy Sciences Major Business
7.5.3 Cell Therapy Sciences Veterinary Regenerative Medicine Product and Services
7.5.4 Cell Therapy Sciences Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Cell Therapy Sciences Recent Developments/Updates
7.5.6 Cell Therapy Sciences Competitive Strengths & Weaknesses
7.6 Dechra
7.6.1 Dechra Details
7.6.2 Dechra Major Business
7.6.3 Dechra Veterinary Regenerative Medicine Product and Services
7.6.4 Dechra Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Dechra Recent Developments/Updates
7.6.6 Dechra Competitive Strengths & Weaknesses
7.7 Enso Discoveries
7.7.1 Enso Discoveries Details
7.7.2 Enso Discoveries Major Business
7.7.3 Enso Discoveries Veterinary Regenerative Medicine Product and Services
7.7.4 Enso Discoveries Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Enso Discoveries Recent Developments/Updates
7.7.6 Enso Discoveries Competitive Strengths & Weaknesses
7.8 South Paws Veterinary Surgical Specialists
7.8.1 South Paws Veterinary Surgical Specialists Details
7.8.2 South Paws Veterinary Surgical Specialists Major Business
7.8.3 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product and Services
7.8.4 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 South Paws Veterinary Surgical Specialists Recent Developments/Updates
7.8.6 South Paws Veterinary Surgical Specialists Competitive Strengths & Weaknesses
7.9 Veterinary Specialty Center
7.9.1 Veterinary Specialty Center Details
7.9.2 Veterinary Specialty Center Major Business
7.9.3 Veterinary Specialty Center Veterinary Regenerative Medicine Product and Services
7.9.4 Veterinary Specialty Center Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Veterinary Specialty Center Recent Developments/Updates
7.9.6 Veterinary Specialty Center Competitive Strengths & Weaknesses
7.10 Vetbiologics
7.10.1 Vetbiologics Details
7.10.2 Vetbiologics Major Business
7.10.3 Vetbiologics Veterinary Regenerative Medicine Product and Services
7.10.4 Vetbiologics Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Vetbiologics Recent Developments/Updates
7.10.6 Vetbiologics Competitive Strengths & Weaknesses
7.11 Vetherapy
7.11.1 Vetherapy Details
7.11.2 Vetherapy Major Business
7.11.3 Vetherapy Veterinary Regenerative Medicine Product and Services
7.11.4 Vetherapy Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Vetherapy Recent Developments/Updates
7.11.6 Vetherapy Competitive Strengths & Weaknesses
7.12 VetStem, Inc.
7.12.1 VetStem, Inc. Details
7.12.2 VetStem, Inc. Major Business
7.12.3 VetStem, Inc. Veterinary Regenerative Medicine Product and Services
7.12.4 VetStem, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 VetStem, Inc. Recent Developments/Updates
7.12.6 VetStem, Inc. Competitive Strengths & Weaknesses
7.13 Zoetis
7.13.1 Zoetis Details
7.13.2 Zoetis Major Business
7.13.3 Zoetis Veterinary Regenerative Medicine Product and Services
7.13.4 Zoetis Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Zoetis Recent Developments/Updates
7.13.6 Zoetis Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Veterinary Regenerative Medicine Industry Chain
8.2 Veterinary Regenerative Medicine Upstream Analysis
8.3 Veterinary Regenerative Medicine Midstream Analysis
8.4 Veterinary Regenerative Medicine Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Veterinary Regenerative Medicine Introduction
1.2 World Veterinary Regenerative Medicine Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Veterinary Regenerative Medicine Total Market by Region (by Headquarter Location)
1.3.1 World Veterinary Regenerative Medicine Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.3 China Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.4 Europe Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.5 Japan Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.6 South Korea Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.7 ASEAN Veterinary Regenerative Medicine Market Size (2018-2029)
1.3.8 India Veterinary Regenerative Medicine Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Veterinary Regenerative Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Veterinary Regenerative Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.2 World Veterinary Regenerative Medicine Consumption Value by Region
2.2.1 World Veterinary Regenerative Medicine Consumption Value by Region (2018-2023)
2.2.2 World Veterinary Regenerative Medicine Consumption Value Forecast by Region (2024-2029)
2.3 United States Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.4 China Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.5 Europe Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.6 Japan Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.7 South Korea Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.8 ASEAN Veterinary Regenerative Medicine Consumption Value (2018-2029)
2.9 India Veterinary Regenerative Medicine Consumption Value (2018-2029)
3 WORLD VETERINARY REGENERATIVE MEDICINE COMPANIES COMPETITIVE ANALYSIS
3.1 World Veterinary Regenerative Medicine Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Veterinary Regenerative Medicine Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Veterinary Regenerative Medicine in 2022
3.2.3 Global Concentration Ratios (CR8) for Veterinary Regenerative Medicine in 2022
3.3 Veterinary Regenerative Medicine Company Evaluation Quadrant
3.4 Veterinary Regenerative Medicine Market: Overall Company Footprint Analysis
3.4.1 Veterinary Regenerative Medicine Market: Region Footprint
3.4.2 Veterinary Regenerative Medicine Market: Company Product Type Footprint
3.4.3 Veterinary Regenerative Medicine Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Veterinary Regenerative Medicine Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Veterinary Regenerative Medicine Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Veterinary Regenerative Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Veterinary Regenerative Medicine Consumption Value Comparison
4.2.1 United States VS China: Veterinary Regenerative Medicine Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Veterinary Regenerative Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Veterinary Regenerative Medicine Companies and Market Share, 2018-2023
4.3.1 United States Based Veterinary Regenerative Medicine Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023)
4.4 China Based Companies Veterinary Regenerative Medicine Revenue and Market Share, 2018-2023
4.4.1 China Based Veterinary Regenerative Medicine Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023)
4.5 Rest of World Based Veterinary Regenerative Medicine Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Veterinary Regenerative Medicine Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Veterinary Regenerative Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Platelet-Rich Plasma (PRP)
5.2.2 Stem Cell Therapy
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Veterinary Regenerative Medicine Market Size by Type (2018-2023)
5.3.2 World Veterinary Regenerative Medicine Market Size by Type (2024-2029)
5.3.3 World Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Veterinary Regenerative Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Veterinary Hospitals/Clinics
6.2.2 Veterinary Research Institutes
6.3 Market Segment by Application
6.3.1 World Veterinary Regenerative Medicine Market Size by Application (2018-2023)
6.3.2 World Veterinary Regenerative Medicine Market Size by Application (2024-2029)
6.3.3 World Veterinary Regenerative Medicine Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 ACell Inc. (Integra LifeSciences)
7.1.1 ACell Inc. (Integra LifeSciences) Details
7.1.2 ACell Inc. (Integra LifeSciences) Major Business
7.1.3 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product and Services
7.1.4 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 ACell Inc. (Integra LifeSciences) Recent Developments/Updates
7.1.6 ACell Inc. (Integra LifeSciences) Competitive Strengths & Weaknesses
7.2 Animal Cell Therapies, Inc.
7.2.1 Animal Cell Therapies, Inc. Details
7.2.2 Animal Cell Therapies, Inc. Major Business
7.2.3 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product and Services
7.2.4 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Animal Cell Therapies, Inc. Recent Developments/Updates
7.2.6 Animal Cell Therapies, Inc. Competitive Strengths & Weaknesses
7.3 Ardent
7.3.1 Ardent Details
7.3.2 Ardent Major Business
7.3.3 Ardent Veterinary Regenerative Medicine Product and Services
7.3.4 Ardent Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Ardent Recent Developments/Updates
7.3.6 Ardent Competitive Strengths & Weaknesses
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Details
7.4.2 Boehringer Ingelheim International GmbH Major Business
7.4.3 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product and Services
7.4.4 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
7.4.6 Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
7.5 Cell Therapy Sciences
7.5.1 Cell Therapy Sciences Details
7.5.2 Cell Therapy Sciences Major Business
7.5.3 Cell Therapy Sciences Veterinary Regenerative Medicine Product and Services
7.5.4 Cell Therapy Sciences Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Cell Therapy Sciences Recent Developments/Updates
7.5.6 Cell Therapy Sciences Competitive Strengths & Weaknesses
7.6 Dechra
7.6.1 Dechra Details
7.6.2 Dechra Major Business
7.6.3 Dechra Veterinary Regenerative Medicine Product and Services
7.6.4 Dechra Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Dechra Recent Developments/Updates
7.6.6 Dechra Competitive Strengths & Weaknesses
7.7 Enso Discoveries
7.7.1 Enso Discoveries Details
7.7.2 Enso Discoveries Major Business
7.7.3 Enso Discoveries Veterinary Regenerative Medicine Product and Services
7.7.4 Enso Discoveries Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Enso Discoveries Recent Developments/Updates
7.7.6 Enso Discoveries Competitive Strengths & Weaknesses
7.8 South Paws Veterinary Surgical Specialists
7.8.1 South Paws Veterinary Surgical Specialists Details
7.8.2 South Paws Veterinary Surgical Specialists Major Business
7.8.3 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product and Services
7.8.4 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 South Paws Veterinary Surgical Specialists Recent Developments/Updates
7.8.6 South Paws Veterinary Surgical Specialists Competitive Strengths & Weaknesses
7.9 Veterinary Specialty Center
7.9.1 Veterinary Specialty Center Details
7.9.2 Veterinary Specialty Center Major Business
7.9.3 Veterinary Specialty Center Veterinary Regenerative Medicine Product and Services
7.9.4 Veterinary Specialty Center Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Veterinary Specialty Center Recent Developments/Updates
7.9.6 Veterinary Specialty Center Competitive Strengths & Weaknesses
7.10 Vetbiologics
7.10.1 Vetbiologics Details
7.10.2 Vetbiologics Major Business
7.10.3 Vetbiologics Veterinary Regenerative Medicine Product and Services
7.10.4 Vetbiologics Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Vetbiologics Recent Developments/Updates
7.10.6 Vetbiologics Competitive Strengths & Weaknesses
7.11 Vetherapy
7.11.1 Vetherapy Details
7.11.2 Vetherapy Major Business
7.11.3 Vetherapy Veterinary Regenerative Medicine Product and Services
7.11.4 Vetherapy Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Vetherapy Recent Developments/Updates
7.11.6 Vetherapy Competitive Strengths & Weaknesses
7.12 VetStem, Inc.
7.12.1 VetStem, Inc. Details
7.12.2 VetStem, Inc. Major Business
7.12.3 VetStem, Inc. Veterinary Regenerative Medicine Product and Services
7.12.4 VetStem, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 VetStem, Inc. Recent Developments/Updates
7.12.6 VetStem, Inc. Competitive Strengths & Weaknesses
7.13 Zoetis
7.13.1 Zoetis Details
7.13.2 Zoetis Major Business
7.13.3 Zoetis Veterinary Regenerative Medicine Product and Services
7.13.4 Zoetis Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Zoetis Recent Developments/Updates
7.13.6 Zoetis Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Veterinary Regenerative Medicine Industry Chain
8.2 Veterinary Regenerative Medicine Upstream Analysis
8.3 Veterinary Regenerative Medicine Midstream Analysis
8.4 Veterinary Regenerative Medicine Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Veterinary Regenerative Medicine Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Veterinary Regenerative Medicine Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Veterinary Regenerative Medicine Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Veterinary Regenerative Medicine Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Veterinary Regenerative Medicine Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Veterinary Regenerative Medicine Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Veterinary Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Veterinary Regenerative Medicine Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Veterinary Regenerative Medicine Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Veterinary Regenerative Medicine Players in 2022
Table 12. World Veterinary Regenerative Medicine Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Veterinary Regenerative Medicine Company Evaluation Quadrant
Table 14. Head Office of Key Veterinary Regenerative Medicine Player
Table 15. Veterinary Regenerative Medicine Market: Company Product Type Footprint
Table 16. Veterinary Regenerative Medicine Market: Company Product Application Footprint
Table 17. Veterinary Regenerative Medicine Mergers & Acquisitions Activity
Table 18. United States VS China Veterinary Regenerative Medicine Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Veterinary Regenerative Medicine Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Veterinary Regenerative Medicine Companies, Headquarters (States, Country)
Table 21. United States Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Veterinary Regenerative Medicine Revenue Market Share (2018-2023)
Table 23. China Based Veterinary Regenerative Medicine Companies, Headquarters (Province, Country)
Table 24. China Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Veterinary Regenerative Medicine Revenue Market Share (2018-2023)
Table 26. Rest of World Based Veterinary Regenerative Medicine Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Veterinary Regenerative Medicine Revenue Market Share (2018-2023)
Table 29. World Veterinary Regenerative Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Veterinary Regenerative Medicine Market Size by Type (2018-2023) & (USD Million)
Table 31. World Veterinary Regenerative Medicine Market Size by Type (2024-2029) & (USD Million)
Table 32. World Veterinary Regenerative Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Veterinary Regenerative Medicine Market Size by Application (2018-2023) & (USD Million)
Table 34. World Veterinary Regenerative Medicine Market Size by Application (2024-2029) & (USD Million)
Table 35. ACell Inc. (Integra LifeSciences) Basic Information, Area Served and Competitors
Table 36. ACell Inc. (Integra LifeSciences) Major Business
Table 37. ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product and Services
Table 38. ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. ACell Inc. (Integra LifeSciences) Recent Developments/Updates
Table 40. ACell Inc. (Integra LifeSciences) Competitive Strengths & Weaknesses
Table 41. Animal Cell Therapies, Inc. Basic Information, Area Served and Competitors
Table 42. Animal Cell Therapies, Inc. Major Business
Table 43. Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product and Services
Table 44. Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Animal Cell Therapies, Inc. Recent Developments/Updates
Table 46. Animal Cell Therapies, Inc. Competitive Strengths & Weaknesses
Table 47. Ardent Basic Information, Area Served and Competitors
Table 48. Ardent Major Business
Table 49. Ardent Veterinary Regenerative Medicine Product and Services
Table 50. Ardent Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Ardent Recent Developments/Updates
Table 52. Ardent Competitive Strengths & Weaknesses
Table 53. Boehringer Ingelheim International GmbH Basic Information, Area Served and Competitors
Table 54. Boehringer Ingelheim International GmbH Major Business
Table 55. Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product and Services
Table 56. Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 58. Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
Table 59. Cell Therapy Sciences Basic Information, Area Served and Competitors
Table 60. Cell Therapy Sciences Major Business
Table 61. Cell Therapy Sciences Veterinary Regenerative Medicine Product and Services
Table 62. Cell Therapy Sciences Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Cell Therapy Sciences Recent Developments/Updates
Table 64. Cell Therapy Sciences Competitive Strengths & Weaknesses
Table 65. Dechra Basic Information, Area Served and Competitors
Table 66. Dechra Major Business
Table 67. Dechra Veterinary Regenerative Medicine Product and Services
Table 68. Dechra Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Dechra Recent Developments/Updates
Table 70. Dechra Competitive Strengths & Weaknesses
Table 71. Enso Discoveries Basic Information, Area Served and Competitors
Table 72. Enso Discoveries Major Business
Table 73. Enso Discoveries Veterinary Regenerative Medicine Product and Services
Table 74. Enso Discoveries Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Enso Discoveries Recent Developments/Updates
Table 76. Enso Discoveries Competitive Strengths & Weaknesses
Table 77. South Paws Veterinary Surgical Specialists Basic Information, Area Served and Competitors
Table 78. South Paws Veterinary Surgical Specialists Major Business
Table 79. South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product and Services
Table 80. South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. South Paws Veterinary Surgical Specialists Recent Developments/Updates
Table 82. South Paws Veterinary Surgical Specialists Competitive Strengths & Weaknesses
Table 83. Veterinary Specialty Center Basic Information, Area Served and Competitors
Table 84. Veterinary Specialty Center Major Business
Table 85. Veterinary Specialty Center Veterinary Regenerative Medicine Product and Services
Table 86. Veterinary Specialty Center Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Veterinary Specialty Center Recent Developments/Updates
Table 88. Veterinary Specialty Center Competitive Strengths & Weaknesses
Table 89. Vetbiologics Basic Information, Area Served and Competitors
Table 90. Vetbiologics Major Business
Table 91. Vetbiologics Veterinary Regenerative Medicine Product and Services
Table 92. Vetbiologics Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Vetbiologics Recent Developments/Updates
Table 94. Vetbiologics Competitive Strengths & Weaknesses
Table 95. Vetherapy Basic Information, Area Served and Competitors
Table 96. Vetherapy Major Business
Table 97. Vetherapy Veterinary Regenerative Medicine Product and Services
Table 98. Vetherapy Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Vetherapy Recent Developments/Updates
Table 100. Vetherapy Competitive Strengths & Weaknesses
Table 101. VetStem, Inc. Basic Information, Area Served and Competitors
Table 102. VetStem, Inc. Major Business
Table 103. VetStem, Inc. Veterinary Regenerative Medicine Product and Services
Table 104. VetStem, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. VetStem, Inc. Recent Developments/Updates
Table 106. Zoetis Basic Information, Area Served and Competitors
Table 107. Zoetis Major Business
Table 108. Zoetis Veterinary Regenerative Medicine Product and Services
Table 109. Zoetis Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of Veterinary Regenerative Medicine Upstream (Raw Materials)
Table 111. Veterinary Regenerative Medicine Typical Customers
Table 1. World Veterinary Regenerative Medicine Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Veterinary Regenerative Medicine Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Veterinary Regenerative Medicine Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Veterinary Regenerative Medicine Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Veterinary Regenerative Medicine Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Veterinary Regenerative Medicine Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Veterinary Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Veterinary Regenerative Medicine Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Veterinary Regenerative Medicine Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Veterinary Regenerative Medicine Players in 2022
Table 12. World Veterinary Regenerative Medicine Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Veterinary Regenerative Medicine Company Evaluation Quadrant
Table 14. Head Office of Key Veterinary Regenerative Medicine Player
Table 15. Veterinary Regenerative Medicine Market: Company Product Type Footprint
Table 16. Veterinary Regenerative Medicine Market: Company Product Application Footprint
Table 17. Veterinary Regenerative Medicine Mergers & Acquisitions Activity
Table 18. United States VS China Veterinary Regenerative Medicine Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Veterinary Regenerative Medicine Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Veterinary Regenerative Medicine Companies, Headquarters (States, Country)
Table 21. United States Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Veterinary Regenerative Medicine Revenue Market Share (2018-2023)
Table 23. China Based Veterinary Regenerative Medicine Companies, Headquarters (Province, Country)
Table 24. China Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Veterinary Regenerative Medicine Revenue Market Share (2018-2023)
Table 26. Rest of World Based Veterinary Regenerative Medicine Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Veterinary Regenerative Medicine Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Veterinary Regenerative Medicine Revenue Market Share (2018-2023)
Table 29. World Veterinary Regenerative Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Veterinary Regenerative Medicine Market Size by Type (2018-2023) & (USD Million)
Table 31. World Veterinary Regenerative Medicine Market Size by Type (2024-2029) & (USD Million)
Table 32. World Veterinary Regenerative Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Veterinary Regenerative Medicine Market Size by Application (2018-2023) & (USD Million)
Table 34. World Veterinary Regenerative Medicine Market Size by Application (2024-2029) & (USD Million)
Table 35. ACell Inc. (Integra LifeSciences) Basic Information, Area Served and Competitors
Table 36. ACell Inc. (Integra LifeSciences) Major Business
Table 37. ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product and Services
Table 38. ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. ACell Inc. (Integra LifeSciences) Recent Developments/Updates
Table 40. ACell Inc. (Integra LifeSciences) Competitive Strengths & Weaknesses
Table 41. Animal Cell Therapies, Inc. Basic Information, Area Served and Competitors
Table 42. Animal Cell Therapies, Inc. Major Business
Table 43. Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product and Services
Table 44. Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Animal Cell Therapies, Inc. Recent Developments/Updates
Table 46. Animal Cell Therapies, Inc. Competitive Strengths & Weaknesses
Table 47. Ardent Basic Information, Area Served and Competitors
Table 48. Ardent Major Business
Table 49. Ardent Veterinary Regenerative Medicine Product and Services
Table 50. Ardent Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Ardent Recent Developments/Updates
Table 52. Ardent Competitive Strengths & Weaknesses
Table 53. Boehringer Ingelheim International GmbH Basic Information, Area Served and Competitors
Table 54. Boehringer Ingelheim International GmbH Major Business
Table 55. Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product and Services
Table 56. Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 58. Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
Table 59. Cell Therapy Sciences Basic Information, Area Served and Competitors
Table 60. Cell Therapy Sciences Major Business
Table 61. Cell Therapy Sciences Veterinary Regenerative Medicine Product and Services
Table 62. Cell Therapy Sciences Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Cell Therapy Sciences Recent Developments/Updates
Table 64. Cell Therapy Sciences Competitive Strengths & Weaknesses
Table 65. Dechra Basic Information, Area Served and Competitors
Table 66. Dechra Major Business
Table 67. Dechra Veterinary Regenerative Medicine Product and Services
Table 68. Dechra Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Dechra Recent Developments/Updates
Table 70. Dechra Competitive Strengths & Weaknesses
Table 71. Enso Discoveries Basic Information, Area Served and Competitors
Table 72. Enso Discoveries Major Business
Table 73. Enso Discoveries Veterinary Regenerative Medicine Product and Services
Table 74. Enso Discoveries Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Enso Discoveries Recent Developments/Updates
Table 76. Enso Discoveries Competitive Strengths & Weaknesses
Table 77. South Paws Veterinary Surgical Specialists Basic Information, Area Served and Competitors
Table 78. South Paws Veterinary Surgical Specialists Major Business
Table 79. South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product and Services
Table 80. South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. South Paws Veterinary Surgical Specialists Recent Developments/Updates
Table 82. South Paws Veterinary Surgical Specialists Competitive Strengths & Weaknesses
Table 83. Veterinary Specialty Center Basic Information, Area Served and Competitors
Table 84. Veterinary Specialty Center Major Business
Table 85. Veterinary Specialty Center Veterinary Regenerative Medicine Product and Services
Table 86. Veterinary Specialty Center Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Veterinary Specialty Center Recent Developments/Updates
Table 88. Veterinary Specialty Center Competitive Strengths & Weaknesses
Table 89. Vetbiologics Basic Information, Area Served and Competitors
Table 90. Vetbiologics Major Business
Table 91. Vetbiologics Veterinary Regenerative Medicine Product and Services
Table 92. Vetbiologics Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Vetbiologics Recent Developments/Updates
Table 94. Vetbiologics Competitive Strengths & Weaknesses
Table 95. Vetherapy Basic Information, Area Served and Competitors
Table 96. Vetherapy Major Business
Table 97. Vetherapy Veterinary Regenerative Medicine Product and Services
Table 98. Vetherapy Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Vetherapy Recent Developments/Updates
Table 100. Vetherapy Competitive Strengths & Weaknesses
Table 101. VetStem, Inc. Basic Information, Area Served and Competitors
Table 102. VetStem, Inc. Major Business
Table 103. VetStem, Inc. Veterinary Regenerative Medicine Product and Services
Table 104. VetStem, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. VetStem, Inc. Recent Developments/Updates
Table 106. Zoetis Basic Information, Area Served and Competitors
Table 107. Zoetis Major Business
Table 108. Zoetis Veterinary Regenerative Medicine Product and Services
Table 109. Zoetis Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of Veterinary Regenerative Medicine Upstream (Raw Materials)
Table 111. Veterinary Regenerative Medicine Typical Customers
LIST OF FIGURES
Figure 1. Veterinary Regenerative Medicine Picture
Figure 2. World Veterinary Regenerative Medicine Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Veterinary Regenerative Medicine Total Market Size (2018-2029) & (USD Million)
Figure 4. World Veterinary Regenerative Medicine Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Veterinary Regenerative Medicine Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 13. Veterinary Regenerative Medicine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 16. World Veterinary Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 18. China Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. India Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Veterinary Regenerative Medicine by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Veterinary Regenerative Medicine Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Veterinary Regenerative Medicine Markets in 2022
Figure 27. United States VS China: Veterinary Regenerative Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Veterinary Regenerative Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Veterinary Regenerative Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Veterinary Regenerative Medicine Market Size Market Share by Type in 2022
Figure 31. Platelet-Rich Plasma (PRP)
Figure 32. Stem Cell Therapy
Figure 33. Others
Figure 34. World Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2029)
Figure 35. World Veterinary Regenerative Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Veterinary Regenerative Medicine Market Size Market Share by Application in 2022
Figure 37. Veterinary Hospitals/Clinics
Figure 38. Veterinary Research Institutes
Figure 39. Veterinary Regenerative Medicine Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Veterinary Regenerative Medicine Picture
Figure 2. World Veterinary Regenerative Medicine Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Veterinary Regenerative Medicine Total Market Size (2018-2029) & (USD Million)
Figure 4. World Veterinary Regenerative Medicine Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Veterinary Regenerative Medicine Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Veterinary Regenerative Medicine Revenue (2018-2029) & (USD Million)
Figure 13. Veterinary Regenerative Medicine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 16. World Veterinary Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 18. China Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. India Veterinary Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Veterinary Regenerative Medicine by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Veterinary Regenerative Medicine Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Veterinary Regenerative Medicine Markets in 2022
Figure 27. United States VS China: Veterinary Regenerative Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Veterinary Regenerative Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Veterinary Regenerative Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Veterinary Regenerative Medicine Market Size Market Share by Type in 2022
Figure 31. Platelet-Rich Plasma (PRP)
Figure 32. Stem Cell Therapy
Figure 33. Others
Figure 34. World Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2029)
Figure 35. World Veterinary Regenerative Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Veterinary Regenerative Medicine Market Size Market Share by Application in 2022
Figure 37. Veterinary Hospitals/Clinics
Figure 38. Veterinary Research Institutes
Figure 39. Veterinary Regenerative Medicine Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
